glp 1 kidney Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection GLP-1 agonists in the treatment

We all have a unique genome, metabolism and microbiome

Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range

, Dieguez, C

Carry your medication in checked luggage only as a last resort, and keep a backup supply refrigerated at your destination

Benefits of GLP-1s Beyond Weight Loss: Neurodegenerative and Joint Disorders Theres even interesting data emerging around neurodegenerative conditions such as Parkinsons and Alzheimers disease

2024 Sales (USD): $13.42 billion Why it sold so well: Gilead Sciences flagship HIV treatment, Biktarvy, had exceptional growth in 2024, with global sales increasing 13% year-over-year to $13.4 billion